antipsychotics
-
anti-obesity medicine, antipsychotics, bipolar disorder, British Journal of Psychiatry Open, Editor Simon Bradstreet, GLP-1 receptor agonists, GLP1, meta-analysis, metabolic health, mortality gap, obesity, physical health, psychosis, schizophrenia, semaglutide, systematic review, tirzepatide, weight gain, weight lossNew heavyweight contender against antipsychotic weight gain? Semaglutide enters the ring
Antipsychotics can be life-changing medications, but they often come with an unwelcome…
-
antipsychotics, biomarkers, brain metabolites, Editor Eimear Foley, first episode psychosis, glutamate, glutamatergic dysfunction, JAMA Psychiatry, mega-analysis, meta-analysis, neuroimaging, personalisation, personalised medicine, prediction, proton magnetic resonance spectroscopy, psychosis, schizophrenia, systematic review, treatment resistance, treatment responseCan brain metabolites predict who responds to antipsychotics?
Antipsychotics are the first choice of treatment for people with schizophrenia or…
-
antipsychotics, BPRS, Drugs, hypoglycemia, lithium, mood stabilizer augmentation, pancytopenia, psychopharmacology, schizophrenia, treatment-resistant schizophrenia, valproateLithium vs. Valproate in Residual Schizophrenia: Case Safety Signal
A 2026 case report described valproate 800 mg/day improving agitation in residual-phase…
-
aggression, antipsychotics, bdnf, cognition, inflammation, left DLPFC, Neurostimulation, randomized trial, risperidone, rtms, schizophreniarTMS Plus Risperidone Improved Schizophrenia Cognition
A 2026 randomized study involving 80 people with schizophrenia found that adding…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, cardiometabolic health, cardiovascular disease, cardiovascular screening, clinical prediction model, cohort study, early intervention in psychosis, Editor Eimear Foley, metabolic syndrome, mixed methods, mortality gap, obesity, personalised care, precision psychiatry, prediction, preventive healthcare, psychosis, risk factors, risk prediction, schizophrenia, severe mental illness, shared decision making, The Lancet Psychiatry, type 2 diabetes, weight gainPsychosis and metabolic risk: PsyMetRiC 2.0 reaches the clinic
Compared to the general population, individuals with psychosis have a 15-year reduced…
-
acute dystonia, antipsychotics, aripiprazole, dopamine blockade, drug-induced dystonia, Drugs, extrapyramidal symptoms, FAERS, haloperidol, Health Science Reports, medication side effects, metoclopramide, pharmacovigilance, Psychiatry, risperidone, side effectsDrug-Induced Dystonia: Metoclopramide and Antipsychotics Lead FAERS
A 2026 FAERS pharmacovigilance study of 28,938 dystonia reports found the strongest…
-
acetate, antipsychotic weight gain, antipsychotics, Anxiety, anxiety disorders, apple cider vinegar, bipolar disorder, depression, Drugs, gut microbiome, HDL cholesterol, LDL cholesterol, medication-related weight gain, metabolic side effects, mood disorders, Psychiatry, psychotropic medications, short-chain fatty acids, side effectsApple Cider Vinegar for Psychotropic Weight Gain: 11 Cases
An 11-person case series tested delayed-release apple cider vinegar capsules in young…
-
agranulocytosis, antipsychotics, clozapine, Drugs, early intervention, FDA REMS, Finnish registry, first episode psychosis, negative symptoms, Psychiatry, psychosis, relapse prevention, schizophrenia, treatment-resistant schizophreniaEarly Clozapine in Schizophrenia: 34% Lower Relapse Risk
Clozapine has been the most effective antipsychotic in schizophrenia for almost 40…
